AGP Executive Report
Last update: 12 hours agoChina Health Strategy: Xi Jinping called for decisive progress on the Healthy China initiative in 2026–30, emphasizing prevention and health across government policies. Drug Innovation: Roche struck a deal worth up to US$1.16 billion with China’s Rona Therapeutics for an experimental obesity drug, including US$100 million upfront. India Access and Affordability: The Supreme Court questioned why medicine price controls cover only cancer drugs, as the Centre told states to ensure hospitals display treatment charges. Pacific Mental Health: A new awareness campaign is urging communities to draw on cultural ties to support wellbeing; health figures show 20% of Pacific people experience high psychological distress. China R&D: Boehringer Ingelheim opened a Shanghai research centre, aiming for full Chinese participation in its early-stage projects. India Medical Technology: Fortis Healthcare introduced what it calls India’s first AI-powered, robot-assisted hybrid cardiac catheterisation lab. Healthcare Costs: Aon projects Asia-Pacific medical costs will rise 9.7% in 2027, a slower increase than in 2026.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
